RoseRx

RoseRx is a revolutionary startup that was founded in 2020 and is based in Australia. The company's mission is encapsulated in its slogan, "A clinical-first, patient-centric platform that empowers patient action & improve access to life-changing treatment." RoseRx operates at the intersection of the Biopharma and Health Care industries. At the core of its operations, RoseRx assists individuals in navigating their health on a large scale. The platform achieves this by ethically empowering patients to take action, thereby accelerating their journey to access life-changing treatment. In September 2021, RoseRx secured a significant $6.65M Series A investment from renowned venture capital firm, Breyer Capital. The company's approach is singularly focused on patient empowerment and improving the accessibility of transformative healthcare solutions. RoseRx's commitment to facilitating patient action and enhancing access to life-changing treatments positions it as an innovative leader within the healthcare space. For further details, visit the company's website.